Sidley Austin LLP advised Vivo Capital and Novo Holdings A/S as lead investors on the deal, while Davis Polk advised Esco Lifesciences. Vivo Capital and Novo...
Esco Lifesciences’ US$200 Million Series A Financing
Zhaoke Ophthalmology Limited’s US$249 Million IPO
Sidley Austin LLP and Kirkland & Ellis advised Zhaoke Ophthalmology Limited on the deal. Sullivan & Cromwell LLP advised the underwriters. Zhaoke Ophthalmology Limited (HKEX:6622) (Zhaoke)...


























